These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 6772562)

  • 1. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.
    Lam J; Chan R; Lam K; Costerton JW
    Infect Immun; 1980 May; 28(2):546-56. PubMed ID: 6772562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative ultrastructure of a mucoid strain of Pseudomonas aeruginosa isolated from cystic fibrosis patient and its spontaneous non-mucoid mutant.
    Dunne WM; Buckmire FL; Kushnaryov VM
    Microbios; 1982; 34(137-38):197-212. PubMed ID: 6817037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoid Pseudomonas in cystic fibrosis.
    Pritt B; O'Brien L; Winn W
    Am J Clin Pathol; 2007 Jul; 128(1):32-4. PubMed ID: 17580270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of adherence of mucoid and nonmucoid Pseudomonas aeruginosa to hamster tracheal epithelium.
    Marcus H; Baker NR
    Infect Immun; 1985 Mar; 47(3):723-9. PubMed ID: 3918937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.
    Singh PK; Schaefer AL; Parsek MR; Moninger TO; Welsh MJ; Greenberg EP
    Nature; 2000 Oct; 407(6805):762-4. PubMed ID: 11048725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.
    Boucher JC; Yu H; Mudd MH; Deretic V
    Infect Immun; 1997 Sep; 65(9):3838-46. PubMed ID: 9284161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 10. Motility as a selective force in the reversion of cystic fibrosis-associated mucoid Pseudomonas aeruginosa to the nonmucoid phenotype in culture.
    Boyce JR; Miller RV
    Infect Immun; 1982 Aug; 37(2):840-4. PubMed ID: 6811443
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.
    Speert DP; Farmer SW; Campbell ME; Musser JM; Selander RK; Kuo S
    J Clin Microbiol; 1990 Feb; 28(2):188-94. PubMed ID: 2107198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoid Escherichia coli in cystic fibrosis.
    Macone AB; Pier GB; Pennington JE; Matthews WJ; Goldmann DA
    N Engl J Med; 1981 Jun; 304(24):1445-9. PubMed ID: 6785645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
    Yu H; Hanes M; Chrisp CE; Boucher JC; Deretic V
    Infect Immun; 1998 Jan; 66(1):280-8. PubMed ID: 9423869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model.
    Bragonzi A; Worlitzsch D; Pier GB; Timpert P; Ulrich M; Hentzer M; Andersen JB; Givskov M; Conese M; Doring G
    J Infect Dis; 2005 Aug; 192(3):410-9. PubMed ID: 15995954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
    Pier GB; Desjardins D; Aguilar T; Barnard M; Speert DP
    J Clin Microbiol; 1986 Aug; 24(2):189-96. PubMed ID: 2943759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
    Malhotra S; Hayes D; Wozniak DJ
    J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U; Wingender J; Jäger KE
    Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early infection and progression of cystic fibrosis lung disease.
    Koch C
    Pediatr Pulmonol; 2002 Sep; 34(3):232-6. PubMed ID: 12203855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.